Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

R-spondin1 Controls Muscle Cell Fusion through Dual Regulation of Antagonistic Wnt Signaling Pathways.

Lacour F, Vezin E, Bentzinger CF, Sincennes MC, Giordani L, Ferry A, Mitchell R, Patel K, Rudnicki MA, Chaboissier MC, Chassot AA, Le Grand F.

Cell Rep. 2017 Mar 7;18(10):2320-2330. doi: 10.1016/j.celrep.2017.02.036.

2.

[How to ask for the assistance of a palliative care network].

Lacour F.

Soins. 2015 Nov;(800):33-4. doi: 10.1016/j.soin.2015.09.006. French.

3.

APC is required for muscle stem cell proliferation and skeletal muscle tissue repair.

Parisi A, Lacour F, Giordani L, Colnot S, Maire P, Le Grand F.

J Cell Biol. 2015 Aug 31;210(5):717-26. doi: 10.1083/jcb.201501053. Epub 2015 Aug 24.

4.

[The role of care assistants at the end of life].

Estrate M, Lacour F.

Rev Infirm. 2015 Feb;(208):33-4. doi: 10.1016/j.revinf.2014.11.012. Epub 2015 Feb 2. French.

PMID:
26144828
5.

[Working together in the patient's home].

Lacour F, Estrate M, Diez F, Benoist C.

Rev Infirm. 2014 Feb;(198):38-40. French.

PMID:
24654335
6.

[Beyond care, the collaboration of freelance nurses in a healthcare network].

Lacour F, Estrate M.

Soins. 2013 May;(775):56-8. French.

PMID:
23785977
7.

Resonant-grating reflection extended to wide-band, large-aperture beams by waveguide-mode coalescence.

Jourlin Y, Tonchev S, Tishchenko AV, Lacour F, Parriaux O.

Opt Express. 2012 Dec 31;20(28):29155-63. doi: 10.1364/OE.20.029155.

PMID:
23388741
8.

[Role and missions of the French Society of Support and Palliative Care].

Lacour F, Hérisson B.

Soins. 2011 Sep;(758):47-9. French.

PMID:
22003796
9.

[Palliative care health networks, bridges between hospital and home].

Lacour F.

Soins. 2011 Sep;(758):38-9. French.

PMID:
22003791
10.

[Reflections on the legalization of euthanasia].

Hirsch G, Hérisson B, Lacour F.

Rev Infirm. 2010 Apr;(159):32-4. French. No abstract available.

PMID:
20432851
11.

[Until the end, caring in life...].

Lacour F.

Soins. 2003 Mar;(673):48-9. French. No abstract available.

PMID:
12677927
12.

Using AN69 ST membrane: a dialysis centre experience.

Maheut H, Lacour F.

Nephrol Dial Transplant. 2001 Jul;16(7):1519-20. No abstract available.

PMID:
11427664
13.

[Professional writing, a collective experience. From thread to needle].

Lacour F.

Soins Form Pedagog Encadr. 1999;(31):4-6. French. No abstract available.

PMID:
10745891
14.

[Renal manifestations of Kimura disease. Apropos of a case].

Maheut H, Arav E, Leone J, Lacour F, Toubas O, Pennaforte JL.

Nephrologie. 1998;19(6):335-40. Review. French.

PMID:
9836195
15.

General pharmacology of S 15261, a new concept for treatment of diabetes.

Duhault J, Berger S, Boulanger M, Della Zuana O, Lacour F, Wierzbicki M.

Arzneimittelforschung. 1998 Jul;48(7):734-44.

PMID:
9706374
16.

S15261 antagonises amylin-induced impaired glucose tolerance.

Espinal J, Lacour F, Berger S, Duhault J.

FEBS Lett. 1995 Jul 10;368(1):36-8.

17.

S15261, a new compound for the treatment of the insulin resistance syndrome.

Duhault J, Lacour F, Boulanger M, Della-Zuana O, Ravel D, Wierzbicki M, Espinal J.

Diabetologia. 1994 Oct;37(10):969-75.

PMID:
7851691
18.

8-OH-DPAT induces a selective increase in protein intake in ageing overweight animals.

Lacour F, Berger S, Espinal J, Duhault J.

Eur J Pharmacol. 1994 Apr 1;255(1-3):249-52.

PMID:
8026551
20.

Improvement in glucose tolerance of insulin resistant rats after chronic or acute administration of benfluorex.

Lacour F, Espinal J, Arnaud O, Duhault J.

Life Sci. 1993;53(20):1525-9.

PMID:
8412519
22.
23.

[Vertebral involvement and fetal alcohol syndrome].

de Cornulier M, de Lacour F, Avet-Loiseau H, Passuti N, Branger B, Lemoine P, Picherot G.

Pediatrie. 1991;46(10):685-9. French.

PMID:
1662356
24.

Huntingtons disease.

Lacour FA Jr.

Ala Med. 1990 Jul-Aug;60(1-2):16, 21-5. Review. No abstract available.

PMID:
2146862
25.

Carpal tunnel syndrome and type of dialysis membrane.

Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F.

BMJ. 1989 Apr 1;298(6677):867-8. No abstract available.

26.

Polyadenylic-polyuridylic acid as adjuvant in the treatment of operable breast cancer: recent results.

Lacour J, Lacour F, Ducot B, Spira A, Michelson M, Petit JY, Sarrazin D, Contesso G.

Eur J Surg Oncol. 1988 Aug;14(4):311-6.

PMID:
3044833
27.

[Therapeutic trial of Poly(A).Poly(U) adjuvant immunotherapy in operable cancer of the breast. Long-term results].

Lacour J, Lacour F, Ducot B, Spira A, Michelson M, Petit JY, Sarrazin D, Contesso G.

Chirurgie. 1988;114(6):516-23. Review. French. No abstract available.

PMID:
3067998
28.

Gastroenteropancreatic peptides and the central nervous system.

Figlewicz DP, Lacour F, Sipols A, Porte D Jr, Woods SC.

Annu Rev Physiol. 1987;49:383-95. Review. No abstract available.

PMID:
3551807
30.

Poly(A).poly(U) as adjuvant in cancer treatment distribution and pharmacokinetics in rabbits.

Michelson AM, Shaool D, Lacour F.

Proc Soc Exp Biol Med. 1985 Jun;179(2):180-6.

PMID:
3991603
31.

Polyadenylic.polyuridylic acid in the cotreatment of cancer.

Michelson AM, Lacour F, Lacour J.

Proc Soc Exp Biol Med. 1985 May;179(1):1-8.

PMID:
2581264
32.

A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients.

Ducret JP, Caillé P, Sancho Garnier H, Amiel JL, Michelson M, Hovanessian AG, Youn JK, Lacour F.

J Biol Response Mod. 1985 Apr;4(2):129-33.

PMID:
3998763
33.

Enhancement of natural killer cell activity and 2-5A synthetase in operable breast cancer patients treated with polyadenylic; polyuridylic acid.

Hovanessian AG, Youn JK, Buffet-Janvresse C, Riviere Y, Michelson M, Lacour J, Lacour F.

Cancer. 1985 Jan 15;55(2):357-62.

PMID:
2578083
34.

A monoclonal antibody to the double-stranded polyribonucleotide complex poly(A) X poly(U).

Delage G, Nahon E, Huynh T, Jeusset J, Lacour F.

Mol Immunol. 1984 Oct;21(10):939-44.

PMID:
6504052
35.

[Does correction of reflux delay the development of renal insufficiency?].

Petit M, Duval F, Lacour F, Prawerman A.

Ann Urol (Paris). 1984 Apr;18(2):130-1. French.

PMID:
6529207
36.

Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.

Lacour J, Lacour F, Spira A, Michelson M, Petit JY, Delage G, Sarrazin D, Contesso G, Viguier J.

Br Med J (Clin Res Ed). 1984 Feb 25;288(6417):589-92.

37.

[Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].

Lacour J, Lacour F, Spira A, Michelson M, Petit JY, Delage G, Sarrazin D, Contesso G, Viguier J.

Chirurgie. 1984;110(4):418-24. French. No abstract available.

PMID:
6389040
38.

Enhancement of natural killer cell activity and 2-5A synthetase in mice treated with polyadenylic.polyuridylic acid.

Youn JK, Hovanessian AG, Riviere Y, Hue G, Lacour F.

Cell Immunol. 1983 Jul 15;79(2):298-308.

PMID:
6872004
40.

Anti-poly(G) . poly(C) antibodies in the serum of patients with systemic lupus erythematosus.

Nahon E, Delfraissy JF, Kahn MF, Jeusset J, Galanaud P, Lacour F.

Clin Immunol Immunopathol. 1982 Mar;22(3):349-62. No abstract available.

PMID:
7105496
41.

The alcohol withdrawal phenomenon and its general management.

Lacour F Sr.

J La State Med Soc. 1982 Jan-Feb;134(1):21-4. No abstract available.

PMID:
7086261
42.

A new adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer.

Lacour F, Lacour J, Spira A, Michelson M, Delage G, Petit JY, Viguier J.

Recent Results Cancer Res. 1982;80:200-6.

PMID:
7036283
43.

Enhancement of interferon-mediated protein kinase in mouse and human plasma in response to treatment with polyadenylic-polyuridylic acid (poly A:poly U).

Hovanessian AG, Rivière Y, Montagnier L, Michelson M, Lacour J, Lacour F.

J Interferon Res. 1982;2(2):209-15.

PMID:
6181177
44.

Altered RNA/protein ratio associated with the induction of differentiation of Friend erythroleukemia cells.

Harel L, Blat C, Lacour F, Friend C.

Proc Natl Acad Sci U S A. 1981 Jun;78(6):3882-6.

45.

[Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)].

Lacour F, Lacour J, Spira A, Michelson M, Petit JY, Delage G, Contesso G, Merlin-Nahon E, Sarrazin D, Viguier J.

Chirurgie. 1980 Nov;106(9):737-43. French. No abstract available.

PMID:
7009093
46.

Adjuvant treatment with polyadenylic-polyuridylic acid (Polya.Polyu) in operable breast cancer.

Lacour J, Lacour F, Spira A, Michelson M, Petit JY, Delage G, Sarrazin D, Contesso G, Viguier J.

Lancet. 1980 Jul 26;2(8187):161-4.

PMID:
6105336
47.
48.

Immunological recognition of three polynucleotide structures associating adenylic and uridylic acids.

Nahon-Merlin E, Michelson AM, Lacour F, Camus G.

Ann Immunol (Paris). 1980 May-Jun;131C(3):279-87.

PMID:
6157347
50.

Early inhibition of phospholipid synthesis in dimethyl sulfoxide (DMSO) treated Friend erythroleukemia (FL) cells.

Harel L, Lacour F, Friend C, Durbin P, Semmel M.

J Cell Physiol. 1979 Oct;101(1):25-32. No abstract available.

PMID:
295286

Supplemental Content

Loading ...
Support Center